Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

Noa Schwartz; Jennifer S. Michaelson; Chaim Putterman

doi:10.1196/annals.1398.032

Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

Noa Schwartz, Jennifer S. Michaelson, Chaim Putterman

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

59 Scopus citations

Abstract

Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). As the course of LN is often unpredictable, it is important to identify reliable, noninvasive methods to repeatedly assess the condition of the kidneys in these patients. Urinary biomarkers are easily obtained and probably are best at reflecting the current renal status, as they specifically represent local inflammatory activity. In this article, we review a number of potential urinary biomarkers, including Lipocalin-2, MCP-1, IP-10, IL-6, and IL-8. Additionally, we provide evidence for the possible utility of the novel cytokine TWEAK as a urinary biomarker for LN.

Original language	English
Title of host publication	Autoimmunity, Part A Basic Principles and New Diagnostic Tools
Publisher	Blackwell Publishing Inc.
Pages	265-274
Number of pages	10
ISBN (Print)	1573316636, 9781573316637
DOIs	https://doi.org/10.1196/annals.1398.032
State	Published - Aug 2007
Externally published	Yes

Publication series

Name	Annals of the New York Academy of Sciences
Volume	1109
ISSN (Print)	0077-8923
ISSN (Electronic)	1749-6632

Keywords

Biomarkers
Lipocalin-2
Lupus nephritis
Systemic lupus erythematosus
TWEAK

Access to Document

10.1196/annals.1398.032

Cite this

@inproceedings{da0191b957304e1d89ca92a26c691ee6,

title = "Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis",

abstract = "Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). As the course of LN is often unpredictable, it is important to identify reliable, noninvasive methods to repeatedly assess the condition of the kidneys in these patients. Urinary biomarkers are easily obtained and probably are best at reflecting the current renal status, as they specifically represent local inflammatory activity. In this article, we review a number of potential urinary biomarkers, including Lipocalin-2, MCP-1, IP-10, IL-6, and IL-8. Additionally, we provide evidence for the possible utility of the novel cytokine TWEAK as a urinary biomarker for LN.",

keywords = "Biomarkers, Lipocalin-2, Lupus nephritis, Systemic lupus erythematosus, TWEAK",

author = "Noa Schwartz and Michaelson, {Jennifer S.} and Chaim Putterman",

year = "2007",

month = aug,

doi = "10.1196/annals.1398.032",

language = "אנגלית",

isbn = "1573316636",

series = "Annals of the New York Academy of Sciences",

publisher = "Blackwell Publishing Inc.",

pages = "265--274",

booktitle = "Autoimmunity, Part A Basic Principles and New Diagnostic Tools",

}

Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis. / Schwartz, Noa; Michaelson, Jennifer S.; Putterman, Chaim.
Autoimmunity, Part A Basic Principles and New Diagnostic Tools. Blackwell Publishing Inc., 2007. p. 265-274 (Annals of the New York Academy of Sciences; Vol. 1109).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

AU - Schwartz, Noa

AU - Michaelson, Jennifer S.

AU - Putterman, Chaim

PY - 2007/8

Y1 - 2007/8

N2 - Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). As the course of LN is often unpredictable, it is important to identify reliable, noninvasive methods to repeatedly assess the condition of the kidneys in these patients. Urinary biomarkers are easily obtained and probably are best at reflecting the current renal status, as they specifically represent local inflammatory activity. In this article, we review a number of potential urinary biomarkers, including Lipocalin-2, MCP-1, IP-10, IL-6, and IL-8. Additionally, we provide evidence for the possible utility of the novel cytokine TWEAK as a urinary biomarker for LN.

AB - Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). As the course of LN is often unpredictable, it is important to identify reliable, noninvasive methods to repeatedly assess the condition of the kidneys in these patients. Urinary biomarkers are easily obtained and probably are best at reflecting the current renal status, as they specifically represent local inflammatory activity. In this article, we review a number of potential urinary biomarkers, including Lipocalin-2, MCP-1, IP-10, IL-6, and IL-8. Additionally, we provide evidence for the possible utility of the novel cytokine TWEAK as a urinary biomarker for LN.

KW - Biomarkers

KW - Lipocalin-2

KW - Lupus nephritis

KW - Systemic lupus erythematosus

KW - TWEAK

UR - http://www.scopus.com/inward/record.url?scp=34848888717&partnerID=8YFLogxK

U2 - 10.1196/annals.1398.032

DO - 10.1196/annals.1398.032

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.conference???

C2 - 17785315

AN - SCOPUS:34848888717

SN - 1573316636

SN - 9781573316637

T3 - Annals of the New York Academy of Sciences

SP - 265

EP - 274

BT - Autoimmunity, Part A Basic Principles and New Diagnostic Tools

PB - Blackwell Publishing Inc.

ER -

Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

Abstract

Publication series

Keywords

Access to Document

Other files and links

Fingerprint

Cite this